Catalyst Biosciences Hemophilia Drug Granted Orphan Status In Europe

Catalyst Biosciences Hemophilia Drug Granted Orphan Status In Europe

Catalyst Biosciences Wednesday reported that the European Commission has granted orphan medicinal product designation to its drug CB 2679d/ISU304, a clinical-stage candidate to treat hemophilia B. The company’s stock traded up 3.8% pre-bell. Catalyst said the orphan drug status offers include the potential for conditional marketing authorization and ten years of market exclusivity in Europe. The company said its drug may provide significant benefits to hemophiliac patients in comparison to […]

Read More ˃
CarMax Upgraded to Outperform by RBC

CarMax Upgraded to Outperform by RBC

CarMax received an investment-rating upgrade Thursday to outperform from sector perform from RBC Capital Markets, a day after the used-vehicles retailer reported fiscal Q1 results above analysts’ expectations. RBC also increased its price target on CarMax’s stock, moving the target to $69 per share from $63. The stock closed Wednesday at $59.74, up 0.8% on the day. For the quarter ended May 31, the company reported earnings per share of […]

Read More ˃
Eni Expands Presence in Mexico

Eni Expands Presence in Mexico

Eni SpA (E), which has been in the Mexico since 2006, said Tuesday it got three out of the 10 offshore blocks awarded by Mexico’s National Hydrocarbon Commission in the Sureste Basin, Gulf of Mexico. ADRs declined more than 2% intraday. The company will operate Block 10 (Eni 100%), Block 7 (Eni 45%, Cairn Energy 30%, Citla Energy 25%) and Block 14 (Eni 60%, Citla 40%), with all of the […]

Read More ˃
Pacific Biosciences of California Prices Public Offering

Pacific Biosciences of California Prices Public Offering

Pacific Biosciences of California has priced its previously announced underwritten public offering of 15,419,354 shares of its common stock at a price of $3.10 per share, equal to a 7.2% discount relative to the stock’s Wednesday closing price. Shares of Pacific Biosciences of California were down 8.7% in recent pre-market trading. Net proceeds of the offering are expected to be approximately $45.9 million, and the offering is expected to close […]

Read More ˃
Futures Trade Lower as Mueller Likely to Open Investigation Into Trump

Futures Trade Lower as Mueller Likely to Open Investigation Into Trump

Stock futures were losing ground ahead of Thursday’s open as political turmoil weighs on Wall Street. The Washington Post reported late Wednesday that special counsel Robert Mueller may open an investigation against president Trump for obstruction of justice. As a result, Dow futures were 78 points below fair value while another sell-off in tech stocks is setting the Nasdaq Composite up for a bruising at the open. At 8:30 am […]

Read More ˃
TransEnterix Sells Robotic Surgery System to Medical University in Tokyo;

TransEnterix Sells Robotic Surgery System to Medical University in Tokyo;

TransEnterix (TRXC), a medical device maker using robotics, disclosed early Thursday the sale of a surgery system to the Saitama Medical University International Medical Center in Tokyo, Japan. Shares rose more than 3% in pre-market. The Senhance robotic surgery system was purchased under a physician import license, which allows medical devices to be directly purchased by Japanese physicians, the company said in a statement. Details of the purchasing price were […]

Read More ˃